Revenue - Nanjing Vazyme Biotech Co Ltd (SSE:688105) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 24.64 CNY -1.28%

Updated:

Nanjing Vazyme Biotech Co Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Nanjing Vazyme Biotech Co Ltd
Revenue Peer Comparison

6160

1801

603392

300122

300896

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
N	Nanjing Vazyme Biotech Co Ltd SSE:688105	Revenue ¥1.3B	CAGR 3-Years -6%	CAGR 5-Years 50%	CAGR 10-Years N/A
	Beigene Ltd HKEX:6160	Revenue ¥17.4B	CAGR 3-Years 102%	CAGR 5-Years 68%	CAGR 10-Years N/A
	Innovent Biologics Inc HKEX:1801	Revenue ¥6.2B	CAGR 3-Years 17%	CAGR 5-Years 266%	CAGR 10-Years N/A
	Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	Revenue ¥5.5B	CAGR 3-Years 33%	CAGR 5-Years 41%	CAGR 10-Years N/A
	Chongqing Zhifei Biological Products Co Ltd SZSE:300122	Revenue ¥53.1B	CAGR 3-Years 48%	CAGR 5-Years 51%	CAGR 10-Years 53%
	Imeik Technology Development Co Ltd SZSE:300896	Revenue ¥1.9B	CAGR 3-Years 51%	CAGR 5-Years 54%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Nanjing Vazyme Biotech Co Ltd's Revenue amounts to 1.3B CNY.

Over the last year, the Revenue growth was -64%. The average annual Revenue growth rates for Nanjing Vazyme Biotech Co Ltd have been -6% over the past three years , 50% over the past five years .

Join more than 139,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.